
Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
The Solution to Ecological Protection: Saving Nature for People in the future - 2
Satellite data reveals a huge solar storm in 2024 shrank Earth's protective plasma shield - 3
This Week In Space podcast: Episode 189 — Privatizing Orbit - 4
Space Condos to Lift Your Metropolitan Living - 5
Instructions to Keep up with Your Traded Teeth for Life span
Flu activity in US could continue to rise for weeks, top CDC epidemiologist says
Nature carves colossal snowman in Siberia | Space photo of the day for Jan. 2, 2026
Fundamental Home Items Each Animal person Needs
All the ways Marjorie Taylor Greene has shifted her approach lately — and why Trump is 'surprised at her'
4K televisions for Extreme Film Watching Experience
Instructions to Utilize Your Brain science Certification to Work on Corporate Culture
Sports Shoes of 2024: Upgrade Execution and Solace
AfD faction in western Germany ousts councilman for firebrand speech
Productive CRM Programming for Client Relationship The executives












